Latest Price Spikes News

Halo Technologies Holdings has responded to ASX queries about a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with continuous disclosure rules.

Stellar Resources has reported strong tin mineralisation results from wedge hole ZS187W1B at its Severn deposit, underpinning resource upgrades and advancing its prefeasibility study at the Heemskirk Tin Project.

Strike Energy has reached key milestones in its South Erregulla Peaking Power Plant project, with engine installations underway and a significant forecast increase in capacity payments boosting revenue prospects.

Manuka Resources has addressed ASX queries about its recent share price and volume spike, attributing the movement to soaring gold and silver prices and its planned production restart in early 2026.

Regener8 Resources has addressed a sharp doubling in its share price, attributing the surge to growing market interest in its North Achilles project amid soaring silver prices and nearby discoveries.

Superior Resources Limited clarifies recent share price jump, attributing it to soaring gold prices and imminent resource updates, while confirming no undisclosed information.

VHM Limited has clarified that a non-binding US$200 million letter of interest from the US Export-Import Bank for its Goschen project is not material to its share price, confirming full compliance with ASX disclosure rules despite recent market speculation.

Findi Limited has responded to ASX inquiries about unusual stock price and volume movements, denying any undisclosed information and announcing legal action against a former subsidiary executive for misleading social media posts.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.

Nordic Resources Ltd attributes its recent share price and volume spike to a successful investor roadshow and capital raising tied to its new Finland gold projects, while confirming full ASX compliance.

Pathkey.AI’s TrialKey platform continues to validate its AI-driven clinical trial success predictions, with September 2025 seeing an average 43.6% share price increase across flagged biotech stocks.

Mount Burgess Mining (MTB) has responded to an ASX price query, confirming no undisclosed material information beyond previously announced gold project acquisitions and debt conversion plans ahead of its upcoming EGM.